When attached to supporting electronics, the sensor can wirelessly transmit data to the user’s cell phone through Bluetooth.
One feature of the COVID-19 virus that makes it so difficult to contain is that it can be easily spread to others by a person who has yet to show any signs of infection. The carrier of the virus might feel perfectly well and go about their daily business–taking the virus with them to work, to the home of a family member, or to public gatherings.
A crucial part of the global effort to stem the spread of the pandemic, therefore, is the development of tests that can rapidly identify infections in people who are not yet symptomatic.
Now, Caltech researchers have developed a new type of multiplexed test (a test that combines multiple kinds of data) with a low-cost sensor that may enable the at-home diagnosis of a COVID infection through rapid analysis of small volumes of saliva or blood, without the involvement of a medical professional, in less than 10 minutes.
The research was conducted in the lab of Wei Gao, assistant professor in the Andrew and Peggy Cherng department of medical engineering.. Previously, Gao and his team have developed wireless sensors that can monitor conditions such as gout, as well as stress levels, through the detection of extremely low levels of specific compounds in blood, saliva, or sweat.
Gao’s sensors are made of graphene, a sheet-like form of carbon. A plastic sheet etched with a laser generates a 3D graphene structure with tiny pores. Those pores create a large amount of surface area on the sensor, which makes it sensitive enough to detect, with high accuracy, compounds that are only present in very small amounts. In this sensor, the graphene structures are coupled with antibodies, immune system molecules that are sensitive to specific proteins, like those on the surface of a COVID virus, for example.
Previous versions of the sensor were impregnated with antibodies for the hormone cortisol, which is associated with stress, and uric acid, which at high concentrations causes gout. The new version of the sensor, which Gao has named SARS-CoV-2 RapidPlex, contains antibodies and proteins that allow it to detect the presence of the virus itself; antibodies created by the body to fight the virus; and chemical markers of inflammation, which indicate the severity of the COVID-19 infection.
“This is the only telemedicine platform I’ve seen that can give information about the infection in three types of data with a single sensor,” Gao says. “In as little as a few minutes, we can simultaneously check these levels, so we get a full picture about the infection, including early infection, immunity, and severity.”
Established COVID-testing technologies usually take hours or even days to produce results. Those technologies also require expensive, complicated equipment, whereas Gao’s system is simple and compact.
So far, the device has been tested only in the lab with a small number of blood and saliva samples obtained for medical research purposes from individuals who have tested positive or negative for COVID-19. Though preliminary results indicate that the sensor is highly accurate, a larger-scale test with real-world patients rather than laboratory samples must be performed, Gao cautions, to definitively determine its accuracy.
With the pilot study now completed, Gao next plans to test how long the sensors last with regular use, and to begin testing them with hospitalized COVID-19 patients. Following in-hospital testing, he would like to study the suitability of the tests for in-home use. Following testing, the device will need to receive regulatory approval before it is available for widespread use at home.
“Our ultimate aim really is home use,” he says. “In the following year, we plan to mail them to high-risk individuals for at-home testing. And in the future, this platform could be modified for other types of infectious disease testing at home.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- The COVID-19 superspreader in the Rose Garden that burst the White House bubbleon October 6, 2020 at 4:29 pm
Amid coronavirus, maskless Supreme Court nomination ceremony turned into a form of biological attack on the top echelons of U.S. government.
- Column: Why the Rose Garden COVID-19 fiasco was dismal news for the return of live entertainmenton October 6, 2020 at 5:19 am
The White House Rose Garden infection fiasco was a test case that suggests rapid testing doesn't work as hoped. It's bad news for the return of live events. Producers and promoters have been seeing ...
- Innovation could improve detection of COVID-19 infectionson October 5, 2020 at 9:33 am
A multidisciplinary research team at the National Institute of Standards and Technology (NIST) has developed a way to increase the sensitivity of the primary test used to detect the SARS-CoV-2 virus, ...
- NIST innovation could improve detection of COVID-19 infectionson October 5, 2020 at 7:24 am
NIST has developed a way to increase the sensitivity of the primary test used to detect the virus that causes COVID-19. Applying the findings could make the nasal swab test up to 10 times more ...
- Use of Coronavirus Rapid Tests May Have Fueled White House Covid-19 Cluster, Experts Sayon October 4, 2020 at 9:54 pm
At least eight people who attended the White House’s recent Supreme Court nomination ceremony for Amy Coney Barrett have tested positive for the coronavirus, and public health experts say they expect ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Rapid detection of COVID-19
- Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnosticson October 6, 2020 at 12:47 pm
Ellume, the company reimagining digital diagnostics, today announced a $30 million Phase 2 award from the U.S. National Institutes of Health (NIH)’s Rapid Acceleration of Diagnostics (RADx) initiative ...
- Quanterix Receives National Institutes of Health RADx Contract to Advance Antigen Test for SARS-CoV-2 (COVID-19)on October 6, 2020 at 12:42 pm
Quanterix Receives National Institutes of Health RADx Contract to Advance Antigen Test for SARS-CoV-2 (COVID-19).
- Multiple options for COVID 19 detection kits by start-ups on the cards through support of CAWACH Initiative of NSTEDB, DSTon October 6, 2020 at 9:59 am
India will soon have the option of choosing from several COVID 19 rapid detection technologies that start-ups are working on currently. A technology to conduct rapid molecular tests at ...
- Multiple options for COVID 19 detection kits by start-ups on the cards through support of CAWACHon October 6, 2020 at 9:02 am
India will soon have the option of choosing from several COVID 19 rapid detection technologies that start-ups are working on currently, the department of Science and Technology (DST) said here on ...
- US Africa Institute Latest Example of America’s Leadership on COVID-19on October 5, 2020 at 11:38 am
The U.S. Africa Institute will ask historically black colleges and universities to lead an effort to strengthen Africa against COVID-19 and other pandemics.